Acrux Ltd

ACR

Company Profile

  • Business description

    Acrux Ltd is a pharmaceutical company dedicated to developing and commercializing generic transdermal and topical prescription pharmaceuticals. The group is formulating and developing a range of topical generic products by leveraging its skilled workforce, on-site laboratories, GMP manufacturing suite, and technical, clinical, and commercial experience to bring affordable products to market. Geographically, it has a presence in Australia; the United States; Europe, and other countries. The firm operates in a single segment and derives revenue from developing and commercializing pharmaceutical products that administer drugs topically. Its product pipeline products include Lenzetto, Evamist, Testosterone Topical Solution, and among others.

  • Contact

    103-113 Stanley Street
    West Melbourne
    MelbourneVIC3003
    AUS

    T: +61 383790100

    E: [email protected]

    https://www.acrux.com.au

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    30 June 2025

    Employees

    36

Stocks News & Analysis

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,640.0015.100.18%
CAC 407,788.1038.69-0.49%
DAX 4024,038.19188.30-0.78%
Dow JONES (US)42,098.70244.95-0.58%
FTSE 1008,726.0152.04-0.59%
HKSE23,408.36150.050.65%
NASDAQ19,100.9498.22-0.51%
Nikkei 22538,327.91605.511.61%
NZX 50 Index12,288.7073.56-0.60%
S&P 5005,888.5532.99-0.56%
S&P/ASX 2008,413.5016.600.20%
SSE Composite Index3,363.9724.040.72%

Market Movers